Applications of Hyperpolarized Agents in Solutions

Methods in Molecular Biology

Volumn 771, Issue , 2011, Pages 655-689

  Ardenkjaer Larsen, Jan Henrik ^a   Jóhannesson, Haukur ^b   Petersson, J Stefan ^a   Wolber, Jan ^a  

^a GE HEALTHCARE   (United Kingdom)

^b REAC Fuel AB   (Sweden)

Author keywords

angiography; Hyperpolarized C 13; metabolic imaging; perfusion

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; CHEMISTRY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIA; MAGNETIC RESONANCE IMAGING;

EID: 80054730107     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-219-9_33     Document Type: Chapter

References (115)

1. Månsson, S., Johansson, E., Magnusson, P., Chai, C.M., Hansson, G., Petersson, J.S., Ståhlberg, F., and Golman, K. (2006) (13)C imaging – a new diagnostic platform. Eur. Radiol. 16, 57–67.
2. Olsson, L.E., Chai, C.-M., Axelsson, O., Karlsson, M., Golman, K., and Petersson, J.S. (2006) MR coronary angiography in pigs with intra arterial injection of a hyperpolarized (13)C substance. Magn. Reson. Med. 55, 731–737.
3. Golman, K. and Petersson, J.S. (2006) Metabolic imaging and other applications of hyperpolarized (13)C. Acad. Radiol. 13, 932–942.
4. Ishii, M., Emami, K., Kadlecek, S., Petersson, J.S., Golman, K, et al. (2007) Hyperpolarized (13)C MRI of the pulmonary vasculature and parenchyma. Magn. Reson. Med. 57, 459–463.
5. Golman, K., Olsson, L.E., Axelsson, O., Månsson, S., Karlsson, M., and Petersson, J.S. (2003) Molecular imaging using hyperpolarized (13)C. Br. J. Radiol. 76, 118–127.
6. 3 He: experiments and theory. J. Magn. Reson. 183, 13–24.
7. Norris D.G. and Hutchison J.M.S. (1990) Concomitant magnetic field gradients and their effects on imaging at low magnetic field strengths. Magn. Reson. Imaging 8, 33–37.
8. Comment, A., van den Brandt, B., Uffmann, K., et al. (2007) Design and performance of a DNP prepolarizer coupled to a rodent MRI scanner. Conc. Magn. Reson. 31, 255–269.
9. Diehl, K.H., Hull, R., Morton, D., Pfis-ter, R., Rabemampianina, Y., Smith, D., Vidal, J.M., and van de Vorstenbosch, C. (2001) European federation of pharmaceutical industries association and European centre for the validation of alternative methods. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol. 21, 15–23.
10. Davies, B. and Morris, T. (1993) Physiological parameters in laboratory animals and humans. Pharm Res. 10, 1093–1095.
11. Oppelt, A., Graumann, R., Barfuss, H., et al. (1986) FISP—a new fast MRI sequence. Electromedica. 54, 15–18.
12. Scheffler, K., Heid, O., and Hennig, J. (2001) Magnetization preparation during the steady state: fat-saturated 3D TrueFISP. Magn. Reson. Med. 45, 1075–1080.
13. Scheffler, K. (2003) On the transient phase of balanced SSFP sequences. Magn. Reson. Med. 49, 781–783.
14. Petersson, J.S. and Christoffersson, J.-O. (1997) A multi-dimensional partition analysis of SSFP image pulse sequences. Magn. Reson. Imaging 15, 451–467.
15. Gyngell, M.L. (1989) The steady-state signals in short-repetition-time sequences. J. Magn. Reson. 81, 474–483.
16. Patz, S. (1989) Steady-state free precession: an overview of basic concepts and applications. Adv Magn Reson Imaging 1, 73–102.
17. Hennig, J. (1991) Echoes—how to generate, recognize, use or avoid them in MR-imaging sequences. Part II: echoes in imaging sequences. Concepts Magn. Reson. 3, 179–192.
18. Deimling, M. and Heid, O. (1994) Magnetization prepared true FISP imaging. Proc. Intl. Soc. Mag. Reson. Med. 495.
19. Svensson, J., Månsson, S., Johansson, E., Petersson, J.S., and Olsson L.E. (2003) Hyperpolarized (13)C MR angiography using TrueFISP. Magn. Reson. Med. 50, 256–262.
20. Hennig, J., Nauerth A., and Friedburg, H. (1986) RARE imaging: a fast imaging method for clinical MR. Magn. Reson. Med. 3, 823–833.
21. Gallagher, F.A., Kettunen, M.I., Day, S.E., Hu, D. E., Ardenkjær-Larsen, J.H., et al. (2008) Magnetic resonance imaging of pH in vivo using hyperpolarized (13) C-labelled bicarbonate. Nature 453, 940–944.
22. Golman, K., Petersson, J.S., Magnusson, P., Johansson, E., et al. (2008) Cardiac metabolism measured noninvasively by hyperpolarized (13)C MRI. Magn. Reson. Med. 59, 1005–1013.
23. Yen, Y.-F., Kohler, S.J., Chen, A.P., Tropp, J., et al. (2009) Imaging considerations for in vivo (13)C metabolic mapping using hyperpolarized (13)C-pyruvate. Magn. Reson. Med. 62, 1–10.
24. 0 shifts in 3D EPSI of the human brain at 4 T. Magn. Reson.Imaging 25, 377–380.
25. Cunningham, C.H., Vigneron, D.B., Chen, A.P., et al. (2005) Design of flyback echo-planar readout gradients for magnetic resonance spectroscopic imaging. Magn. Reson. Med. 54, 1286–1289.
26. Chen, A.P., Alberts, M.J., Chunningham, C.H., et al. (2007) Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T—initial experience. Magn. Reson. Med. 58, 1099–1106.
27. Thévenaz, P., Blu, T., and Unser, M. (2000) Interpolaton revisited. IEEE Trans. Med. Imaging 19, 739–758.
28. Yaroslavsky, L.P. (2001) Signal sinc-interpolation: a fast computer algorithm. Bioimaging 4, 225–231.
29. Bracewell, R.N. (1986) The Fourier Transform and Its Applications. McGraw-Hill: New York.
30. 13 C pyruvate. J. Magn. Reson. 200, 344–348.
31. 13 C dynamic chemical-shift imaging. J. Magn. Reson. 194, 121–127.
32. 1 H decoupling. J. Magn. Reson. 197, 100–106.
33. Ljunggren, S. (1983) A simple graphical representation of Fourier-based imaging methods. J. Magn. Reson. 54, 338–343.
34. Ahn, C.B., Kim, J.H., and Cho, Z.H. (1986) High-speed spiral-scan echo planar NMR imaging. IEEE Trans. Med. Imaging 5, 2–7.
35. 13 C metabolic imaging. Magn. Reson. Med. 58, 245–252.
36. 13 C1-pyruvate. Magn. Reson. Med. 62, 557–564.
37. Cunningham C.H., Chen, A.P., Lustig, M., Hargreaves, B.A., Lupo, J., Xu, D., Kurhanewics, J., Hurd, R.E., Pauly, J.M., Nelson, S.J., and Vigneron, D.B. (2008) Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J. Magn. Reson. 193, 139–146.
38. Leupold, J., Wieben, O., Månsson, S., Speck, O., Scheffler, K., Petersson, J.S., and Hennig J. (2006) Fast chemical shift mapping with multiecho balanced SSFP. MAGMA 19, 267–273.
39. Vinitski, S., Mitchell, D.G., Szumowski, J., Burk, D.L., and Rifkin, M.D. (1990) Variable flip angle imaging and fat suppression in combined gradient and spin-echo (GREASE) techniques. Magn. Reson. Imaging 8, 131–139.
40. Dixon, W.T. (1984) Simple proton spectroscopic imaging. Radiology 153, 189–194.
41. Glover, G.H. (1991) Multipoint Dixon technique for water and fat proton and susceptibility imaging. J. Magn. Reson. Imaging 1, 521–530.
42. Reeder, S.B., Wen, Z., Yu, H., Angel, A.R., et al. (2004) Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn. Reson. Med. 51, 35–45.
43. Leupold, J., Månsson, S., Petersson, J.S., Hennig, J., and Wieben, O. (2009) Fast multiecho balanced SSFP metabolite mapping (1)H and hyperpolarized (13)C compounds. MAGMA 22, 251–256.
44. Golman, K., Axelsson, O., Jóhannesson, H., Månsson, S., Olofsson, C., and Petersson, J.S. (2001) Parahydrogen-induced polarization in imaging: subsecond (13)C angiography. Magn. Reson. Med. 46, 1–5.
45. Golman, K., Ardenkjær-Larsen, J.H., Svensson, J., et al. (2002) (13)C-angiography. Acad. Radiol. 2, 507–510.
46. Golman, K., Ardenkjær-Larsen, J.H., Petersson, J. S., Månsson, S., and Leunbach, I. (2003) Molecular imaging with endogenous substances. Proc. Natl. Acad. Sci. U.S.A. 100, 10435–10439.
47. Magnusson, P., Johansson, E., Månsson, S., Petersson, J.S., et al. (2007) Passive catheter tracking during interventional MRI using hyperpolarized (13)C. Magn. Reson. Med. 57, 1140–1147.
48. Østergaard, L., Weisskoff, R.M., Chesler, D.A., Gyldensted, C., and Rosen, B.R. (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn. Reson. Med. 36, 715–725.
49. Østergaard, L., Sorensen, A.G., Kwong, K.K., Weisskoff, R.M., Gyldensted, C., and Rosen, B.R. (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn. Reson. Med. 36, 726–736.
50. Johansson, E. (2003) NMR imaging of flow and perfusion using hyperpolarized nuclei. PhD thesis, Lund University, Lund.
51. Johansson, E., Månsson, S., Wirenstam, R., Svensson, J., Petersson, J.S., Golman, K., and Ståhlberg, F. (2004) Cerebral perfusion assessment by bolus tracking using hyperpolarized (13)C. Magn. Reson. Med. 51, 464–472.
52. Meier, P. and Zierler, K. (1954) On the theory of the indicator-dilution method for assessment of blood flow and volume. J. Appl. Physiol. 6, 731–744.
53. Goodson, B.M., Song, Y.Q., Taylor, R.E., et al. (1997) In vivo NMR and MRI using injection delivery of laser-polarized xenon. Proc. Natl. Acad. Sci. U.S.A. 94, 14725–14729.
54. Duhamel, G., Choquet, P., Grillon, E., et al. (2002) Global and regional cerebral blood flow measurements using NMR of injected hyperpolarized Xenon-129. Acad. Radiol. 9, 498–500.
55. Kety, S.S. (1949) Measurements of regional circulation by the local clearance of radioactive sodium. Am. Heart J. 38, 321–328.
56. Kety, S.S. (1951) The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol. Rev. 3, 1–41.
57. Peled, S., Jolesz, F.A., Tseng, C.H., Nascimben, L., Albert, M.S., and Walsworth R.L. (1996) Determinants of tissue delivery for (129)Xe magnetic resonance in humans. Magn. Reson. Med. 36, 340–344.
58. Martin, C.C., Williams, R.F., Gao, J.H., Nickerson, L.D.H., Xiong, J., and Fox, P.T. (1997) The pharmacokinetics of hyperpolarized xenon: implications for cerebral MRI. J. Magn. Reson Imaging 7, 848–854.
59. Lavini, C., Payne, G.S., Leach, M.O., and Bifone, A. (2000) Intravenous delivery of hyperpolarized (129)Xe: a compartmental model. NMR Biomed. 13, 238–244.
60. Killian, W., Seifert, F., and Rinneberg, H. (2002) Time resolved (129)Xe spectroscopy of human brain after inhaling hyperpolarized xenon gas. Proc. Intl. Soc. Mag. Reson. Med.
61. Johansson, E., Olsson, L.E., Månsson, S., Petersson, J.S., Golman, K., Ståhlberg, F., and Wirenstam, R. (2004) Perfusion assessment with bolus differentiation: a technique applicable to hyperpolarized tracers. Magn. Reson. Med. 52, 1043–1051.
62. Golman, K., in’t Zandt, R., and Thaning, M. (2006) Real-time metabolic imaging. PNAS. 103, 11270–11275.
63. 13 C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res. 66, 10855–10860.
64. 13 C magnetic resonance imaging and spectroscopy. Nat. Med. 13, 1382–1387.
65. Berg, J.M., Tymoczko, J.L., and Stryer, L. (2007) Biochemistry, sixth edition, W.H. Freeman and Company, New York, USA.
66. Gatenby, R.A. and Gillies, R.J. (2004). Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891–899.
67. Yagi, G. and Hoberman, H.D. (1969) Rate of isotope exchange in enzyme-catalyzed reactions. Biochemistry 8, 352–360.
68. Borgmann, U., Moon, T.W. and Laidler, K.J. (1974) Molecular kinetics of beef heart lactate dehydrogenase. Biochemistry 13, 5152–5158.
69. Poole, R.C. and Halestrap, A.P. (1993) Transport of lactate and other monocar-boxylates across mammalian plasma membranes. Am. J. Physiol. 264, 761–782.
70. Jackson, V.N. and Halestrap, A.P. (1996) The kinetic, substrate and inhibitor specificity of the monocarboxylate (lac-tate) transporter of rat liver cells determined using the fluorescent intracellular pH indicator 2’,7’-Bis(carboxyethyl)-5(6)-carboxyfluorescein. J. Biol. Chem. 271, 861–868.
71. Lin, R.Y., Vera, J.C., Chaganti, R.S.K., and Golde, D.W. (1998) Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J. Biol. Chem. 273, 28959–28965.
72. Brindle, K.M. (1988) NMR methods for measuring enzyme kinetics in vivo. Prog. Nucl. Magn. Reson. Spectrosc. 20, 257–293.
73. 13 C magnetic resonance imaging and spectroscopy. Nat. Med. 13, 1382–1387.
74. 13 C1-pyruvate metabolism in normal rats and TRAMP mice. J. Magn. Reson. 202, 85–92.
75. 13 C]pyruvate. Magn. Reson. Med. 62, 307–313.
76. Naressi, A., Couturier, C., Devos, J.M., Janssen, M., Mangeat, C., de Beer, R., and Graveron-Demilly, D. (2001) Java-based graphical user interface for the MRUI quantitation package. Magn. Reson. Mater. Biol., Phys., Med. 12, 141–152.
77. http://s-provencher.com/pages/lcmodel. shtml.
78. Shaw, R.J. (2006). Glucose metabolism and cancer. Curr. Opin. Cell Biol. 18, 598–608.
79. Meisamy, S., Bolan, P.J., Baker, E.H., Bliss, R.L., Gulbahce, E., Everson, L.I., Nelson, M.T., Emory, T.H., Tut-tle, T.M., Yee, D., et al. (2004). Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo H-1 MR spectroscopy – A pilot study. Radiology 233, 424–431.
80. Kurhanewicz, J., Vigneron, D.B., and Nelson, S.J. (2000). Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2, 166–189.
81. 1 H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma in tumours. Cancer Res. 58, 1063–1067.
82. Veech, R.L., Lawson, J.W.R., Cornell, N.W., and Krebs, H.A. (1979) Cytosolic phosphorylation potential. J. Biol. Chem. 254, 6538–6547.
83. Silverstein, E. and Boyer, P.D. (1964) Equilibrium reaction rates and the mechanism of bovine heart and rabbit muscle lactate dehydrogenase. J. Biol. Chem. 239, 3901–3907.
84. 31 P MRS. Magn. Reson. Med. 40, 411–420.
85. 13 C-labeled pyruvate utilization as methods for detecting tumor response to treatment. Neoplasia 11, 574–582.
86. Moffat, B.A., Chenevert, T.L., Lawrence, T.S., Meyer, C.R., Johnson, T.D., Dong, Q., Tsien, C., Mukherji, S., Quint, D.J., Gebarski, S.S., et al. (2005). Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc. Natl. Acad. Sci. U.S.A. 102, 5524–5529.
87. 13 C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res. 68, 8607–8615.
88. Bode, B.P. and Souba, W.W. (1994) Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells. Ann. Surg. 220, 411–422.
89. Reitzer, L.J., Wice, B.M., and Kennell, D. (1979) Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254, 2669–2676.
90. 13 C-labeled glutamine. Magn. Reson. Med. 60, 253–257.
91. 13 C]-fructose: a hemiketal DNP substrate for in vivo metabolic imaging. J. Am. Chem. Soc. Online.
92. 13 C ketoisocaproate. Inter. J. Cancer. Online.
93. Panchal, A.R., Comte, B., Huang, H., Kerwin, T., Darvish, A., Des Rosiers, C., Brunengraber, H., and Stanley, W.C. (2000). Partitioning of pyruvate between oxidation and anaplerosis in swine hearts. Am. J. Physiol. Heart Circ. Physiol. 279, 2390–2398.
94. Panchal, A.R., Comte, B., Huang, H., Dudar, B., Roth, B., Chandler, M., Des Rosiers, C., Brunengraber, H., and Stanley, W.C. (2001). Acute hibernation decreases myocardial pyruvate carboxylation and citrate release. Am. J. Physiol. Heart Circ. Physiol. 281, 1613–1620.
95. Mallet, R.T. (2000) Pyruvate: metabolic protector of cardiac performance. Proc. Soc. Exp. Biol. Med. 223, 136–148.
96. Mallet, R.T., Sun, J., Knott, E.M., Sharma, A.B., and Olivencia-Yurvati, A.H. (2005) Metabolic cardioprotection by pyruvate: recent progress. Exp. Biol. Med. 230, 435–443.
97. Schroeder, M.A., Atherton, H.J., Cochlin, L.E., Clarke, K., Radda, G.K., and Tyler, D.J. (2009) The effect of hyperpolarized tracer concentration on myocardial uptake and metabolism. Magn. Reson. Med. 61, 1007–1014.
98. Tyler, D.J., Schroeder, M.A., Cochlin, L.E., Clarke, K., and Radda, G.K (2008) Applications of hyperpolarized magnetic resonance in the study of cardiac metabolism. Appl. Magn. Reson. 34, 523–531.
99. 13 C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc. Natl. Acad. Sci. U.S.A. 104, 19773–19777.
100. 3 . Magn. Reson. Med. 60, 1029–1036.
101. Schroeder, M.A., Cochlin, L.E., Heather, L.C., Clarke, K., Radda, G.K., and Tyler, D.J. (2008) In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc. Natl. Acad. Sci. U.S.A. 105, 12051–12056.
102. Stanley, W.C., Recchia, F.A., and Lopaschuk, G.D. (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093–1129.
103. Jager, P.L., Vaalburg, W., Pruim, J., de Vries, E.G.E., Langen, K.J., and Piers, D.A. (2001). Radiolabeled amino acids: basic aspects and clinical applications in oncology. J. Nucl. Med. 42, 432–445.
104. 13 C magnetic resonance spectroscopy. The FASEB J. 23.
105. Michaelis, T., Boretius, S., and Frahm, J. (2009) Localized proton MRS of animal brain in vivo: models of human disorders. Progr. Nucl. Magn. Reson. Spectrosc. 55, 1–34.
106. Tran, T., Ross, B., and Lin, A. (2009) Magnetic resonance spectroscopy in neurological diagnosis. Neurologic Clinics 27, 21–60.
107. 13 C-succinate imaging of brain cancer. J. Magn. Reson. 186, 150–155.
108. 13 C] ethyl pyruvate. Magn. Reson. Med. 63, 1137–1143.
109. 13 C]pyruvate. Magn. Reson. Med. 62, 307–313.
110. 13 C-labelled bicarbonate. Nature 453, 940–944.
111. Adrogué, H.G., Gennari, F.J., Galla, J.H., and Madias, N.E. (2009) Assessing acid– base disorders. Kidney Int. 76, 1239–1247.
112. Casey, J.R., Grinstein, S., and Orlowski, J. (2010) Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol. 11, 50–61.
113. Raghunand, N., He, X., van Sluis, R., Mahoney, B., Baggett, B., Taylor, C.W., Paine-Murrieta, G., Roe, D., Bhujwalla, Z.M., and Gillies, R.J. (1999) Enhancement of chemotherapy by manipulation of tumour pH. Br. J. Cancer 80, 1005–1011.
114. Robey, I.F., Baggett, B.K., Kirkpatrick, N.D., Roe, D.J., Dosescu, J., Sloane, B.F., Hashim, A.I., Morse, D.L., Raghunand, N., Gatenby, R.A., and Gillies, R.J. (2009) Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 69, 2260–2268.
115. Gillies, R.J., Raghunand, N., Garcia-Martin, M.L., and Gatenby, R.A. (2004) pH imaging: a review of pH measurement methods and applications in cancers. IEEE Eng. Med. Biol. Mag. 23, 57–64.